The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...
Research at a Duke University laboratory led to a new breast cancer drug in 2023. Government funding for that lab is now in ...
As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key. Leucovorin is prescribed ...
For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants who had no cognitive problems at the study's start and who took the drug ...
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a ...
The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback